Antiplatelet regimens following carotid artery revascularization

Dual antiplatelet therapy (DAPT) is indicated following carotid artery stenting (CAS) and single antiplatelet therapy (SAPT) following carotid endarterectomy (CEA), but it remains unknown how providers adhere to these guidelines in real-world clinical practice. Using the Vascular Quality Initiative...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2022-11, Vol.253, p.48-52
Main Authors: Lee, Megan, Ahmed, Zain V., Huang, Jiaming, Brice, Aaron, Arham, Ahmad, Castro-Dominguez, Yulanka, Aboian, Edouard, Nagpal, Sameer, Smolderen, Kim G., Mena-Hurtado, Carlos
Format: Article
Language:English
Subjects:
Anticoagulants
Aspirin
Asymptomatic
Cardiac arrhythmia
Cardiovascular disease
Carotid Arteries
Carotid artery
Carotid Stenosis - surgery
Cerebrovascular disease
Coronary vessels
Diabetes
Endarterectomy, Carotid
Humans
Hypertension
Kidney diseases
Patients
Platelet Aggregation Inhibitors - therapeutic use
Retrospective Studies
Risk Factors
Statistical analysis
Stents
Stroke
Stroke - drug therapy
Treatment Outcome
Variables
Vein & artery diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dual antiplatelet therapy (DAPT) is indicated following carotid artery stenting (CAS) and single antiplatelet therapy (SAPT) following carotid endarterectomy (CEA), but it remains unknown how providers adhere to these guidelines in real-world clinical practice. Using the Vascular Quality Initiative New England data, we found that of 12,257 patients, 82% patients were discharged on DAPT following CAS and 66% were discharged on SAPT following CEA. While a high percentage of patients undergoing CAS appropriately receive DAPT, the use of SAPT following CEA exists with more variability and lower adherence rates.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2022.07.004